Gedeon, P. C. (2018). A Rationally Designed Fully Human EGFRvIII: CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationGedeon, P. C. A Rationally Designed Fully Human EGFRvIII: CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationGedeon, P. C. A Rationally Designed Fully Human EGFRvIII: CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.